Mechanisms of Fusion-Driven Oncogenesis in Childhood Cancers (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-23-036 from the NIH Guide for Grants and Contracts. NCI is forming the Targeting Fusion Oncoproteins in Childhood Cancers (TFCC) Network to advance our understanding of the mechanisms of action of fusion oncoproteins in pediatric cancers and to apply novel chemical strategies for developing targeted therapeutic approaches. This RFA will use the U01 mechanism to solicit applications focused on molecular mechanisms by which fusion oncoproteins drive pediatric cancers with the goals of better understanding the biology of these cancers and identifying potential drug targets or critical dependencie...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 17, 2023 Category: Research Source Type: funding
Pediatric Immunotherapy Network (PIN) (U01 Clinical Trial Optional)
Funding Opportunity RFA-CA-22-016 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) intends to solicit applications for the Pediatric Immunotherapy Network (PIN). The overall goal of this FOA is to establish a collaborative network consisting of investigators with relevant expertise to develop and advance novel translational immunotherapy approaches for children and adolescents with solid tumors including brain tumors. This FOA solicits U01 applications for discrete research projects that address relevant research opportunities focused o...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 5, 2022 Category: Research Source Type: funding
Limited Competition: Pediatric Brain Tumor Consortium (UM1 Clinical Trials Required)
Funding Opportunity RFA-CA-19-059 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is intended to continue support for the Pediatric Brain Tumor Consortium (PBTC). This Limited-Competition FOA solicits a single application from the current PBTC awardee. The PBTC was conceived as a dedicated clinical trials organization able to translate innovative therapies from the laboratory to early phase clinical testing so that treatment for primary brain tumors in children can be improved. The importance of the PBTC is highlighted by the continuing high mortality rate among some common brain...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 23, 2019 Category: Research Source Type: funding
Microbial-based Cancer Therapy -Bugs as Drugs (R21 Clinical Trial Not Allowed)
Funding Opportunity PAR-19-194 from the NIH Guide for Grants and Contracts. The overall purpose of this funding opportunity announcement (FOA) is to stimulate the development of novel microbial-based cancer therapies, especially for conditions where conventional cancer therapies are inadequate, such as poorly vascularized, hypoxic, solid tumors, dormant or slowly dividing cells resistant to current interventions, and brain tumors. Utilizing bacteria, archaebacteria, bacteriophages and other non-virus microorganisms, this initiative will support research projects designed to study the underlying mechanisms of the complex...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 22, 2019 Category: Research Source Type: funding
Microbial-based Cancer Therapy -Bugs as Drugs (R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-19-193 from the NIH Guide for Grants and Contracts. The overall purpose of this funding opportunity announcement (FOA) is to stimulate the development of novel microbial-based cancer therapies, especially for conditions where conventional cancer therapies are inadequate, such as poorly vascularized, hypoxic, solid tumors, dormant or slowly dividing cells resistant to current interventions, and brain tumors. Utilizing bacteria, archaebacteria, bacteriophages and other non-virus microorganisms, this initiative will support research projects designed to study the underlying mechanisms of the complex...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 22, 2019 Category: Research Source Type: funding
2015 Prevention of Acquired Epilepsies Award
CURE seeks novel research projects of relevance to the prevention, treatment and cures of acquired (post-insult) epilepsies including: (1) the cellular, molecular, and systems-level understanding of the underlying pathogenic mechanisms; (2) specific approaches to modify the development of acquired epilepsy; (3) animal models of acquired epilepsy; and (4) investigations of the impact, natural history, and epidemiology of acquired epilepsy. For the purposes of this program, "acquired epilepsies" are defined as epilepsies which result from injury to the brain, including but not limited to traumatic brain injury...
Source: ScanGrants feed - December 8, 2014 Category: Research Authors: Citizens United for Research in Epilepsy (CURE) Source Type: funding
Sontag Foundation Distinguished Scientist Awards
2015 Application deadline is March 19, 2015. Inspire us. We're looking for early career scientists with the potential to create new waves across the brain cancer field. We're looking for increased survival rates and improved recovery for patients. We're looking for a cure or at the very least, treatments to make brain cancer a manageable chronic disease. Eligibility Requirements for 2015 Distinguished Scientist Awards Applicants must hold a doctoral degree in a discipline which can be brought to bear on the intractable disease, brain cancer. At the time of application, applicants must hold ...
Source: ScanGrants feed - December 2, 2014 Category: Research Authors: Sontag Foundation Source Type: funding
Call for Applications: American Brain Tumor Association Basic Research Fellowship Program
All applications for 2015-2017 American Brain Tumor Association Basic Research Fellowships must be completed online through www.abtagrants.org. The application submission deadline, including all supporting documents and letters, is 12 pm, noon (CT), Wednesday, January 7, 2015. The American Brain Tumor Association seeks applications from outstanding new and early career investigators wishing to begin a two-year, brain tumor Basic Research Fellowship July 1, 2015. The intent of this program is to encourage talented scientists early in their careers to enter, or remain in, the field of brain tumor research. These...
Source: ScanGrants feed - December 1, 2014 Category: Research Authors: American Brain Tumor Association Source Type: funding
2015 American Brain Tumor Association Medical Student Summer Fellowship
All applications for the 2015 American Brain Tumor Association Medical Student Summer Fellowship must be completed online through www.abtagrants.org. The application submission deadline, including all supporting documents and letters is 12pm, noon (CT), Wednesday, January 28, 2015. ABTA Medical Student Summer Fellowships are $3,000 grants to medical students wishing to spend a summer conducting brain tumor research. The fellowship is to be conducted in a neuro-oncology laboratory with a mentorship setting that will provide an introductory learning experience. Studies are to be conducted at laboratories in the ...
Source: ScanGrants feed - December 1, 2014 Category: Research Authors: American Brain Tumor Association Source Type: funding
2015-2016 Neurosurgery Research and Education Foundation Young Clinician Investigator Award
Founded by the American Association of Neurological Surgeons (AANS) in 1981, the Neurosurgery Research and Education Foundation (NREF) is the premier foundation supporting neurosurgical research. It supports neurosurgical residents and young neurosurgical faculty in North America conducting basic science, patient-oriented clinical, and outcomes research. This NREF-supported research — on neurosurgical disorders ranging from brain tumors and epilepsy to spine disorders and Parkinson's Disease — seeks to improve patient care and quality of life through advances in disorder diagnosis and treatment. Th...
Source: ScanGrants feed - October 1, 2014 Category: Research Authors: Neurosurgery Research and Education Foundation Source Type: funding
Call for Applications: Sontag Foundation Distinguished Scientist Awards
Inspire us. We're looking for early career scientists with the potential to create new waves across the brain cancer field. We're looking for increased survival rates and improved recovery for patients. We're looking for a cure or at the very least, treatments to make brain cancer a manageable chronic disease. Next Application deadline is March 20, 2014. Eligibility Requirements for 2014 Distinguished Scientist Awards Applicants must hold a doctoral degree in a discipline which can be brought to bear on the intractable disease, brain cancer. At the time of application, applicants must hold ...
Source: ScanGrants feed - February 3, 2014 Category: Research Authors: Sontag Foundation Source Type: funding
Pediatric Brain Tumor Foundation Scholarship Program
The Pediatric Brain Tumor Foundation has expanded its scholarship program with the addition of the multiyear Galaxy Scholarship. The new multiyear Galaxy Scholarship award complements the one-year award provided by the original PBTF scholarship program launched in 2002. This year we have also introduced an online-only application format for both awards. Our scholarship program eases the financial hardships of a childhood brain tumor diagnosis and helps survivors reach their academic goals. Scholarships are supported in part by the Cycle World Joseph C. Parkhurst Education Fund. Galaxy Scholarship The G...
Source: ScanGrants feed - December 11, 2013 Category: Research Authors: Pediatric Brain Tumor Foundation Source Type: funding
Limited Competition: Adult Brain Tumor Consortium (ABTC) (UM1)
Funding Opportunity Number: RFA-CA-13-501 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: EducationHealthCFDA Number: 93.395Eligible Applicants Others (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name: HHS-NIH11Closing Date: Sep 16, 2013Award Ceiling: $2,000,000Expected Number of Awards: 1Creation Date: Jun 19, 2013Funding Opportunity Description: The purpose of this limited competition Funding Opportunity Announcement (FOA) is to continue the program of the National Cancer I...
Source: Grants.gov - July 31, 2013 Category: Research Tags: Education Health Source Type: funding
Limited Competition: Pediatric Brain Tumor Consortium (UM1)
Funding Opportunity Number: RFA-CA-13-502 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: EducationHealthCFDA Number: 93.395Eligible Applicants Others (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name: HHS-NIH11Closing Date: Sep 16, 2013Award Ceiling: $2,590,000Expected Number of Awards: Creation Date: Jun 19, 2013Funding Opportunity Description: This Funding Opportunity Announcement (FOA) is intended to continue support for the Pediatric Brain Tumor Consortium (PBTC). This l...
Source: Grants.gov - July 31, 2013 Category: Research Tags: Education Health Source Type: funding
Clarifications for Applicants Responding to RFA-CA-13-502 Limited Competition: Pediatric Brain Tumor Consortium (UM1)
Notice NOT-CA-13-014 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 10, 2013 Category: Research Source Type: funding
